Tavapadon
Nkọwa ngwaahịa
Mkpado ngwaahịa
Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
10mg | Dị na ngwaahịa | 210 |
100mg | Dị na ngwaahịa | 450 |
1g | Dị na ngwaahịa | 1900 |
Aha kemịkalụ:
1,5-dimethyl-6-[2-methyl-4-[3- (trifluoromethyl) pyridin-2-yl] oxyphenyl] pyrimidine-2,4-dione
Koodu Ọchịchọ:
O=C1NC(C(C)=C(C2=CC=C(OC3=NC=CC=C3C(F)(F)F)C=C2C)N1C)=O
Koodu InChi:
InChi=1S/C19H16F3N3O3/c1-10-9-12(28-17-14(19(20,21)22)5-4-8-23-17)6-7-13(10)15-11( 2)16 (26)24-18 (27)25(15)3/h4-9H,1-3H3, (H,24,26,27)
Igodo InChi:
AKQXQLUNFKDZBN-UHFFFAOYSA-N
Okwu:
1643489-24-0;CAS:1643489-24-0;CAS:1643489-24-0;Tavapadon; PF-6649751; PF 6649751; PF6649751; CVL-751; CVL 751; CVL751
Solubility:Soluble na DMSO
Nchekwa:Akọrọ, ọchịchịrị na na 0 - 4 C maka obere oge (ụbọchị ruo izu) ma ọ bụ -20 C maka ogologo oge (ọnwa ruo afọ).
Nkọwa:
Tavapadon, nke a makwaara dị ka PF-6649751 na CVL-751, bụ agonist dopamine receptor akụkụ. Ọ nwere ike ịba uru na ọgwụgwọ ọrịa Parkinson na Alzheimer.
Ebumnuche: Dopamine d1/d5 ndị na-anabata akụkụ agonists